These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 19830876

  • 1. Your genetic makeup is an Alzheimer's risk predictor. If you know you carry a gene that boosts your risk of AD, you may make better decisions about your future.
    Duke Med Health News; 2009 Oct; 15(10):4-5. PubMed ID: 19830876
    [No Abstract] [Full Text] [Related]

  • 2. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A, Aldudo J, Recuero M, Sastre I, Vilella-Cuadrada E, Rosich-Estragó M, Frank A, Valdivieso F, Bullido MJ.
    Dement Geriatr Cogn Disord; 2008 Oct; 26(5):440-4. PubMed ID: 18957849
    [Abstract] [Full Text] [Related]

  • 3. Effect of genetic testing for risk of Alzheimer's disease.
    Kane RA, Kane RL.
    N Engl J Med; 2009 Jul 16; 361(3):298-9. PubMed ID: 19605835
    [No Abstract] [Full Text] [Related]

  • 4. Disclosure of the genetic risk of Alzheimer's disease.
    Gordon SC, Landa D.
    N Engl J Med; 2010 Jan 14; 362(2):181-2; author reply 182. PubMed ID: 20071713
    [No Abstract] [Full Text] [Related]

  • 5. [Genetics of Alzheimer's disease].
    Hannequin D, Campion D, Dumanchin C, Martinez M, Agid Y, Clerget-Darpoux F, Frebourg T, Brice A.
    Rev Neurol (Paris); 1998 Jan 14; 154 Suppl 2():S65-74. PubMed ID: 9834545
    [Abstract] [Full Text] [Related]

  • 6. Genetic heterogeneity of Alzheimer's disease: complexity and advances.
    Lambert JC, Amouyel P.
    Psychoneuroendocrinology; 2007 Aug 14; 32 Suppl 1():S62-70. PubMed ID: 17659844
    [Abstract] [Full Text] [Related]

  • 7. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P, Caraci F, Copani A, Spada RS, Sortino MA, Salluzzo R, Salemi M, Nicoletti F, Ferri R.
    Neurosci Lett; 2007 Jun 04; 419(3):195-8. PubMed ID: 17498878
    [Abstract] [Full Text] [Related]

  • 8. Genetics. Once shunned, test for Alzheimer's risk headed to market.
    Couzin J.
    Science; 2008 Feb 22; 319(5866):1022-3. PubMed ID: 18292309
    [No Abstract] [Full Text] [Related]

  • 9. Virology. Alzheimer's risk factor also aids HIV.
    Youngsteadt E.
    Science; 2008 Jun 20; 320(5883):1577. PubMed ID: 18566258
    [No Abstract] [Full Text] [Related]

  • 10. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
    Mauri M, Sinforiani E, Bono G, Cittadella R, Quattrone A, Boller F, Nappi G.
    Funct Neurol; 2006 Jun 20; 21(4):223-8. PubMed ID: 17367583
    [Abstract] [Full Text] [Related]

  • 11. One step closer to defining Alzheimer's causes. ApoE4 gene identified as possible target for drug therapy in Alzheimer's treatment.
    Duke Med Health News; 2012 Aug 20; 18(8):6. PubMed ID: 23029675
    [No Abstract] [Full Text] [Related]

  • 12. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
    Huang Y.
    Trends Mol Med; 2010 Jun 20; 16(6):287-94. PubMed ID: 20537952
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B, Carson R, Barrett SL, Craig D, Passmore AP.
    Neurosci Lett; 2010 Oct 08; 483(1):62-6. PubMed ID: 20678545
    [Abstract] [Full Text] [Related]

  • 14. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G.
    Neurobiol Dis; 2007 Mar 08; 25(3):609-13. PubMed ID: 17174555
    [Abstract] [Full Text] [Related]

  • 15. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE, Koedam EL, Pijnenburg YA, Twisk JW, Scheltens P, van der Flier WM.
    Psychol Med; 2009 Nov 08; 39(11):1907-11. PubMed ID: 19335933
    [Abstract] [Full Text] [Related]

  • 16. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J, Hannequin D, Pasquier F, Bentham P, Brice A, Leber I, Frebourg T, Deleuze JF, Cousin E, Thaker U, Amouyel P, Mann D, Lendon C, Campion D, Lambert JC.
    Neurobiol Dis; 2008 Apr 08; 30(1):103-6. PubMed ID: 18272374
    [Abstract] [Full Text] [Related]

  • 17. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS, Heun R, Jessen F, Popp J, Hentschel F, Kelemen P, Schulz A, Maier W, Kölsch H.
    Neurobiol Aging; 2009 May 08; 30(5):691-6. PubMed ID: 17904251
    [Abstract] [Full Text] [Related]

  • 18. Depressive symptoms associated with hereditary Alzheimer's disease: a case description.
    Contreras MY, Vargas PA, Ramos LR, Velandia RA.
    Am J Alzheimers Dis Other Demen; 2009 May 08; 21(6):411-5. PubMed ID: 17267373
    [Abstract] [Full Text] [Related]

  • 19. Molecular genetics of Alzheimer's disease: an update.
    Brouwers N, Sleegers K, Van Broeckhoven C.
    Ann Med; 2008 May 08; 40(8):562-83. PubMed ID: 18608129
    [Abstract] [Full Text] [Related]

  • 20. Alzheimer's research. How to talk about Alzheimer's risk.
    Miller G.
    Science; 2012 Aug 17; 337(6096):792. PubMed ID: 22903992
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.